Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis.
Yildirim-Toruner
Cagri
C
Kimura
Yukiko
Y
Rabinovich
Egla
E
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D000068800:Etanercept; D005260:Female; D006689:Hodgkin Disease / Q000209:etiology*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007223:Infant; D000069285:Infliximab; D008297:Male; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept